chr20-45952664-GTCAC-G
Position:
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_022095.4(ZNF335):c.2744_2747delGTGA(p.Ser915fs) variant causes a frameshift change. The variant allele was found at a frequency of 0.000131 in 1,613,832 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: 𝑓 0.00016 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00013 ( 0 hom. )
Consequence
ZNF335
NM_022095.4 frameshift
NM_022095.4 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 4.41
Genes affected
ZNF335 (HGNC:15807): (zinc finger protein 335) The protein encoded by this gene enhances transcriptional activation by ligand-bound nuclear hormone receptors. However, it does this not by direct interaction with the receptor, but by direct interaction with the nuclear hormone receptor transcriptional coactivator NRC. The encoded protein may function by altering local chromatin structure. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 20-45952664-GTCAC-G is Pathogenic according to our data. Variant chr20-45952664-GTCAC-G is described in ClinVar as [Likely_pathogenic]. Clinvar id is 375393.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr20-45952664-GTCAC-G is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000158 AC: 24AN: 152150Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
24
AN:
152150
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000121 AC: 30AN: 248128Hom.: 0 AF XY: 0.000119 AC XY: 16AN XY: 134330
GnomAD3 exomes
AF:
AC:
30
AN:
248128
Hom.:
AF XY:
AC XY:
16
AN XY:
134330
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000128 AC: 187AN: 1461564Hom.: 0 AF XY: 0.000136 AC XY: 99AN XY: 727050
GnomAD4 exome
AF:
AC:
187
AN:
1461564
Hom.:
AF XY:
AC XY:
99
AN XY:
727050
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000158 AC: 24AN: 152268Hom.: 0 Cov.: 33 AF XY: 0.000121 AC XY: 9AN XY: 74450
GnomAD4 genome
AF:
AC:
24
AN:
152268
Hom.:
Cov.:
33
AF XY:
AC XY:
9
AN XY:
74450
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Microcephalic primordial dwarfism due to ZNF335 deficiency Pathogenic:5
Likely pathogenic, criteria provided, single submitter | research | Duke University Health System Sequencing Clinic, Duke University Health System | Apr 20, 2023 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Jun 17, 2020 | - - |
Pathogenic, no assertion criteria provided | research | Lupski Lab, Baylor-Hopkins CMG, Baylor College of Medicine | - | This variant was identified as compound heterozygous in an individual with developmental delay, intellectual disability, seizures, hypomyelination, and failure to thrive. - |
Pathogenic, criteria provided, single submitter | clinical testing | Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center | Mar 26, 2024 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Sep 01, 2017 | This frameshift variant is categorized as deleterious according to ACMG guidelines (PMID:18414213) and was found twice in our laboratory: in trans with an inframe deletion (V242del) in a 3-year-old female with idiopathic pulmonary arterial hypertension, significant delays, hypotonia, microcephaly, dysmorphisms, broad thumbs and halluxes, hirsutism. A similarly affected microcephalic sister was also compound heterozygous. Also found in trans with a nonsense variant (E1263X) in an 8-year-old male with microcephaly, intellectual disability, seizures, hypomyelination, partial cytochrome c oxidase deficiency. - |
not provided Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Dec 26, 2023 | Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Reported in a patient with developmental delay, seizures, hypomyelination, and failure to thrive who harbored a second pathogenic ZNF335 variant, however, segregation information was not provided (Eldomery et al., 2017); This variant is associated with the following publications: (PMID: 31216405, 31589614, 25326635, 34426522, 28327206) - |
Pathogenic, no assertion criteria provided | clinical testing | Laboratory of Molecular Genetics (Pr. Bezieau's lab), CHU de Nantes | Jul 06, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at